Evolent Health (EVH) Reports Q4 Loss, Lags Revenue Estimates
Portfolio Pulse from
Evolent Health (EVH) reported a Q4 loss of $0.02 per share, matching the Zacks Consensus Estimate, but lagged behind revenue expectations. This is a decline from the $0.23 per share earnings reported a year ago.
February 21, 2025 | 12:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Evolent Health reported a Q4 loss of $0.02 per share, meeting the consensus estimate but missing revenue expectations. This marks a decline from last year's earnings of $0.23 per share.
The reported loss and missed revenue expectations are likely to negatively impact EVH's stock price in the short term. The decline from last year's earnings further adds to the negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100